Drug-induced respiratory emergencies

Respiratory Emergencies

Volumn , Issue , 2006, Pages 169-290

  Bonniaud, Philippe ^a   Camus, Clio ^a   Jibbaoui, Ahmad ^a   Kazambu, Kabeya ^a   Baudouin, Nicolas ^a   Foucher, Pascal ^a   Camus, Philippe ^a  

^a Intensive Care University Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49449089277     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (203)

1. Pneumotox® website. Produced by P Foucher - Ph Camus. www.pneumotox.com, last update: March, 2006.
2. White DA. Drug-induced pulmonary infection. Clin Chest Med 2004; 25: 179-88.
3. Wolff AJ, O'Donnell AE. Pulmonary effects of illicit drug use. Clin Chest Med 2004; 25: 203-16.
4. Wilson KC, Saukkonen JJ. Acute respiratory failure from abused substances. J Intensive Care Med 2004; 19: 183-93.
5. Duong T, Schonfeld AJ, Yungbluth M, Slotten R. Acute pneumopathy in a nonsurgical transsexual. Silicone emboli to the lung. Chest 1998; 113: 1127-9.
6. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 2001; 13:242-8.
7. Ernst E. Harmless herbs?A review of the recent literature. Am J Med 1998; 104: 170-8.
8. Talbot AR, Shaiw MH, Huang JS, et al. Intentional self-poisoning with glyphosate containing herbicides (Roundup): a review of93 cases. Hum Exp Toxicol 1991; 10: 1-8.
9. Park CH, Kim KI, Park SK, Lee CH. Carbamate poisoning: High resolution CT and pathologic findings. J Comput Assist Tomogr 2000; 24: 52-4.
10. Plataki M, Bouros D. Iatrogenic and rare pleural effusion. In: Bouros D, ed. Pleural Disorders. New York: Marcel Dekker, 2004: 897-913.
11. Similowski T, Straus C. Iatrogenic-induced dysfunction of the neuromuscular respiratory system. Clin Chest Med 2004; 25: 155-66.
12. Flieder DB, Travis WD. Pathologic characteristics of drug-induced lung disease. Clin Chest Med 2004; 25: 37-46.
13. Camus P, Bonniaud P, Fanton A, et al. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med 2004; 25: 479-519, vi.
14. Ibanez L, Laporte JR, Carne X. Adverse drug reactions leading to hospital admission. Drug Saf 1991; 6: 450-9.
15. Mertes PM, Laxenaire MC. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002). Ann Fr Anesth Reanim 2004; 23: 1133-43.
16. Shapiro S, Slone D, Lewis GP, Jick H. Fatal drug reactions among medical inpatients. JAMA 1971; 216: 467-72.
17. Sondhi D, Lippmann M, Murali G. Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital. Chest 2004; 126: 400-4.
18. Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment ofhypertensive heart disease. J Forensic Sci 2001; 46: 1239-43.
19. Cohen EG, Soliman AMS. Changing trends in angioedema. Ann Otol Rhinol Laryngol 2001; 110: 701-6.
20. Camus P. Drug-induced respiratory disease in connective tissue diseases. In: Wells AU, Denton CP, eds. Handbook of Systemic Autoimmune Diseases Part VI: Pulmonary Involvement in Systemic Autoimmune Diseases. Vol. 2: Elsevier BV, 2004: 247-94.
21. Roberts JR, Wuerz RC. Clinical characteristics of angiotensin-converting enzyme inhibitor-induced angioedema. Ann Emerg Med 1991; 20: 119-22.
22. Schuster C, Reinhart WH, Hartmann K, Kuhn M. Angioödem unter ACE-Hemmern and Angiotensin-II-receptor-Antagonisten: Analyse von 98 Fällen. Schweiz Med Wochenschr 1999; 129: 362-9.
23. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992; 117:234-42.
24. Seidman MD, Lewandowski CA, Sarpa JR, et al. Angioedema related to angiotensin-converting enzyme inhibitors. Otolaryngol Head Neck Surg 1990; 102: 727-31.
25. Chiu AG, Krowiak EJ, Deeb ZE. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology. Laryngoscope 2001; 111: 1729-31.
26. Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: A review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108: 861-6.
27. Gruchalla RS, Pirmohamed M. Clinical practice. Antibiotic allergy. N Engl J Med 2006; 354: 601-9.
28. Pumphrey RSH. Lessons from management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144-50.
29. Shanholtz C. Acute life-threatening toxicity ofcancer treatment. Crit Care Clin 2001; 17: 483-502.
30. Berkes EA. Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs. Clin Rev Allergy Immunol 2003; 24: 137-47.
31. Shepherd GM. Hypersensitivity reactions to drugs: evaluation and management. Mt Sinai J Med 2003;70: 113-25.
32. Sicherer SH. Advances in anaphylaxis and hypersensitivity reactions to foods, drugs, and insect venom. J Allergy Clin Immunol 2003; 111: S829-34.
33. Amin HS, Liss GM, Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 2006; 117: 169-75.
34. Leung DY, Shanahan WR, Jr, Li XM, Sampson HA. New approaches for the treatment of anaphylaxis. Novartis Found Symp 2004; 257: 248-60; discussion 260-74, 276-85.
35. Kaplinsky N, Deutsch V, Har Zahav V, Frankl O. Mediastinal bleeding during anticoagulant simulating dissecting hematoma. Harefuah 1978; 94: 172-3.
36. Turetz F, Steinberg H, Kahn A. Spontaneous anterior mediastinal hematoma: a complication of heparin therapy. J Am Med Womens Assoc 1979; 34: 85-8.
37. al-Fallouji HK, Snow DG, Kuo MJ, Johnson PJ. Spontaneous retropharyngeal haematoma: two cases and a review of the literature. J Laryngol Otol 1993; 107: 649-50.
38. Kaynar AM, Bhavani-Shankar K, Mushlin PS. Lingual hematoma as a potential cause of upper airway obstruction. Anesth Analg 1999; 89: 1573-5.
39. Shojania KG. Coumadin-induced lingual hemorrhage mimicking angioedema. Am J Med 2000; 109:77-8.
40. Ahmed J, Philpott J, Lew GS, Blunt D. Airway obstruction: a rare complication of thrombolytic therapy. J Laryngol Otol 2005; 119: 819-21.
41. Gupta MK, McClymont LG, El-Hakim H. Case of sublingual hematoma threatening airway obstruction. Med Sci Monit 2003; 9: CS95-7.
42. Götte K, Hormann K. Dyspnea caused by spontaneous hematoma of the oropharynx and larynx during marcumar therapy. HNO 2001; 49: 220-3.
43. Boyce SH, Quigley MA. Uvulitis and partial upper airway obstruction following cannabis inhalation. Emerg Med (Fremantle) 2002; 14: 106-8.
44. O'Donnell AE, Selig J, Aravamuthan M, Richardson MSA. Pulmonary complications associated with illicit drug use. An update. Chest 1995; 108: 460-3.
45. White MC, Reynolds F. Sudden airway obstruction following inhalation drug abuse. Br J Anaesth 1999; 82: 808.
46. Huggins JT, Kaplan A, Martin-Harris B, Sahn SA. Eucalyptus as a specific irritant causing vocal cord dysfunction. Ann Allergy Asthma Immunol 2004; 93: 299-303.
47. Perry PA, Dean BS, Krenzelok EP. Drug-induced esophageal injury. J Toxicol Clin Toxicol 1989; 27: 281-6.
48. Stack PE, Thomas E. Pharmacobezoar: an evolving new entity. Dig Dis 1995; 13: 356-64.
49. Plaza V, Serrano J, Picado C, Sanchis J. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J 2002; 19: 846-52.
50. Babu KS, Marshall BG. Drug-induced airways diseases. Clin Chest Med 2004; 25: 113-22.
51. Babu KS, Salvi SS. Aspirin and asthma. Chest 2000; 118: 1470-6.
52. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. Eur Respir J 2000; 16: 432-8.
53. Mascia K, Haselkorn T, Deniz YM, et al. Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2005; 116: 970-5.
54. Marquette CH, Saulnier F, Leroy O, et al. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992; 146: 76-81.
55. Berges-Gimeno MP, Simon RA, Stevenson DD. Longterm treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003; 111: 180-6.
56. Ramanuja S, Breall JA, Kalaria VG. Approach to 'aspirin allergy' in cardiovascular patients. Circulation 2004; 110: e1-4.
57. Pleskow WW, Stevenson DD, Mathison DA, et al. Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982; 69: 11-19.
58. Rosado A, Vives R, Gonzalez R, Rodriguez J. Can NSAIDs intolerance disappear?A study of three cases. Allergy 2003; 58: 689-90.
59. Fallowfield JM, Marlow HF. Propranolol is contraindicated in asthma. BMJ 1996; 313: 1486.
60. Lang DM, Alpern MB, Visintainer PF, Smith ST. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med 1993; 153: 2033-40.
61. Krantz AJ, Hershow RC, Prachand N, et al. Heroin insufflation as a trigger for patients with life-threatening asthma. Chest 2003; 123: 510-17.
62. Rivera MP, Kris MG, Gralla RJ, White DA. Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapy. Am J Clin Oncol 1995; 18:245-50.
63. Shepherd GM. Hypersensitivity reactions to chemotherapeutic drugs. Clin Rev Allergy Immunol 2003; 24: 253-62.
64. Camus P. Drug-induced infiltrative lung diseases. In: Schwarz MI, King TEJ, eds. Infiltrative Lung Diseases, 4th ed. Hamilton, ON: BC Dekker, Inc; 2003: 485-534.
65. Cleverley JR, Screaton NJ, Hiorns MP, et al. Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol 2002; 57: 292-9.
66. Glauser FL, DeBlois G, Bechard D, et al. Cardiopulmonary toxicity of adoptive immunotherapy. Am J Med Sci 1988; 296: 406-12.
67. Ramanathan RK, Belani CP. Transient pulmonary infiltrates: a hypersensitivity reaction to paclitaxel. Ann Intern Med 1996; 124: 278.
68. Maillard N, Foucher P, Caillot D, et al. Transient pulmonary infiltrates during treatment with anti-thymocyte globulin. Respiration 1999; 66: 279-82.
69. Krantz MJ, Dart RC, Mehler PS. Transient pulmonary infiltrates possibly induced by quinine sulfate. Pharmacotherapy 2002; 22: 775-8.
70. Karacan O, Eyüboglu FO, Akcay S, Özyilkan Ö. Acute interstitial pneumopathy associated with docetaxel hypersensitivity. Onkologie 2004; 27: 563-5.
71. Varnell RM, Godwin JD, Richardson ML, Vincent JM. Adult respiratory distress syndrome from overdose of tricyclic antidepressants. Radiology 1989; 170: 667-70.
72. Silber R, Clerkin EP. Pulmonary edema in acute heroin poisoning. Report of four cases. Am J Med 1959; 27: 187-92.
73. Brass BJ, Winchester-Penny S, Lipper BL. Massive verapamil overdose complicated by noncardiogenic pulmonary edema. Am J Emerg Med 1996; 14: 459-61.
74. Chaouat A, Kessler R, Weitzenblum E. Pulmonary oedema and pleural effusion in two patients with primary pulmonary hypertension treated with calcium channel blockers. Heart 1996; 75: 383.
75. Lee-Chiong TLJ, Matthay RA. Drug-induced pulmonary edema and acute respiratory distress syndrome. Clin Chest Med 2004; 25: 95-104.
76. Doria C, Mandal AL, Scott VL, et al. Noncardiogenic pulmonary edema induced by a molecular adsorbent recirculating system: case report. J Artificial Organs 2003; 6: 282-5.
77. Sickmann K, Seider R, Dahm M, Nold H. Negative pressure pulmonary edema. Anaesthesist 2005; 54: 1197-200.
78. Hong SJ, Lee JY, Choi JH, et al. Pulmonary edema following laparoscopic bariatric surgery. Obes Surg 2005; 15: 1202-6.
79. Westreich R, Sampson I, Shaari CM, Lawson W. Negative-pressure pulmonary edema after routine septorhinoplasty - Discussion of pathophysiology, treatment, and prevention. Arch Facial Plast Surg 2006; 8: 8-15.
80. Bouachour G, Varache N, Szapiro N, et al. Noncardiogenic pulmonary edema resulting from intravascular administration of contrast material. AJR Am J Roentgenol 1991; 157: 255-6.
81. Paul RE, George G. Fatal noncardiogenic pulmonary edema after intravenous nonionic radiographic contrast. Lancet 2002; 359: 1037-8.
82. Franquet T, Muller NL, Lee KS, et al. High-resolution CT and pathologic findings of noninfectious pulmonary complications after hematopoietic stem cell transplantation. AJR Am J Roentgenol 2005; 184:629-37.
83. Shearer P, Katz J, Bozeman P, et al. Pulmonary insufficiency complicating therapy with high dose cytosine arabinoside in five pediatric patients with relapsed acute myelogenous leukemia. Cancer 1994; 74: 1953-8.
84. Pavlakis N, Bell DR, Millward MJ, Levi JA. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 1997; 80: 286-91.
85. Gonzolez ER, Cole T, Grimes MM, Fink RA, Fowler AAI. Recurrent ARDS in an 39-year-old woman with migraine headaches. Chest 1998; 114: 919-22.
86. Semba S, Moriya T, Youssef EM, Sasano H. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol Int 2000; 50: 549-52.
87. Erasmus JJ, McAdams HP, Rossi SE. Drug-induced lung injury. Semin Roentgenol 2002; 37: 72-81.
88. Kopko PM, Popovsky MA. Pulmonary injury from transfusion-related acute lung injury. Clin Chest Med 2004; 25: 105-13.
89. Popovsky MA. Transfusion and lung injury. Transfus Clin Biol 2001; 8:272-7.
90. Camus P, Costabel U. Drug-induced respiratory disease in patients with hematological diseases. Semin Respir Crit Care Med 2005; 26: 458-81.
91. Dubois M, Lotze MT, Diamond WJ, et al. Pulmonary shunting during leukoagglutinin-induced noncardiac pulmonary edema. JAMA 1980; 244: 2186-9.
92. Yost CS, Matthay MA, Gropper MA. Etiology of acute pulmonary edema during liver transplantation. Chest 2001; 119:219-23.
93. Popovsky MA. Transfusion and the lung: circulatory overload and acute lung injury. Vox Sang 2004; 87: 62-5.
94. Gajic O, Moore SB. Transfusion-related acute lung injury. Mayo Clin Proc 2005; 80: 766-70.
95. Levy GJ, Shabot MM, Hart ME, et al. Transfusion-associated noncardiogenic pulmonary edema. Report of a case and a warning regarding treatment. Transfusion 1986; 26: 278-81.
96. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury. Report of a clinical look-back investigation. JAMA 2002; 287: 1968-71.
97. Frankel SR, Eardley A, Lauwers G, et al. The 'retinoic acid syndrome' in acute promyelocytic leukemia. Ann Intern Med 1992; 117: 292-6.
98. Vosburgh E. Pulmonary leukostasis secondary to alltrans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse. Leukemia 1992; 6: 608-10.
99. Davis BA, Cervi P, Amin Z, et al. Retinoic acid syndrome: pulmonary computed tomography (CT) findings. Leuk Lymphoma 1996; 23: 113-17.
100. Krous HF, Hamlin WB. Pulmonary toxicity due to bleomycin. Report of a case. Arch Pathol 1973; 95:407-10.
101. Litam JP, Dail DH, Spitzer G, et al. Early pulmonary toxicity after administration of high-dose BCNU. Cancer Treat Rep 1981; 65: 39-43.
102. Andersson BS, Luna BS, Yee C, et al. Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer 1990; 65:1079-84.
103. Mack U, Schmidt K, Heine M. Fatal diffuse alveolar damage after gold medication. Pneumologie 1994; 48:405-8.
104. Dai MS, Ho CL, Chen YC, et al. Acute respiratory distress syndrome following intrathecal methotrexate administration: a case report and review of literature. Ann Hematol 2000; 79: 696-9.
105. Savici D, Katzenstein ALA. Diffuse alveolar damage and recurrent respiratory failure: Report of 6 cases. Hum Pathol 2001; 32: 1398-402.
106. Kramer N, Chuzhin Y, Kaufman LD, et al. Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum 2002; 47: 670-1.
107. Oon PC, Jerng JS, Kao HL, et al. Diffuse alveolar damage associated with ticlopidine use: a case report. J Formos Med Assoc 2003; 102: 262-5.
108. Manito N, Kaplinsky EJ, Bernat R, et al. Fatal interstitial pneumonitis associated with sirolimus therapy in a heart transplant recipient. J Heart Lung Transplant 2004; 23: 780-2.
109. Seto T, Seki N, Uematsu K, et al. Gefitinib-induced lung injury successfully treated with high-dose corticosteroids. Respirology 2006; 11: 113-16.
110. Johkoh T,Itoh H,Müller NL, et al. Crazy-paving appearance at thin-section CT: Spectrum ofdisease and pathologic findings. Radiology 1999; 211:155-60.
111. Rossi SE, Erasmus JJ, McAdams P, et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. RadioGraphics 2000; 5: 1245-59.
112. Roychowdhury M, Pambuccian SE, Aslan DL, et al. Pulmonary complications after bone marrow transplantation. An autopsy study from a large transplantation center. Arch Pathol Lab Med 2005; 129: 366-71.
113. Limper AH. Chemotherapy-induced lung disease. Clin Chest Med 2004; 25: 53-64.
114. Mulabecirovic A, Gaulhofer P, Auner HW, et al. Pulmonary infiltrates in patients with haematologic malignancies: transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis. Ann Hematol 2004; 83: 420-2.
115. Brockstein BE, Smiley C, Al-Sadir J, Williams SF. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplant 2000; 25: 885-94.
116. Friedberg JW, Neuberg D, Kim H, et al. Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease. Unacceptable acute pulmonary toxicity. Cancer 2003; 98: 978-82.
117. Bhalla KS, Wilczynski SW, Abushamaa AM, et al. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support. Am J Respir Crit Care Med 2000; 161: 17-25.
118. Dai MS, Lee SC, Ho CL, et al. Impact of open lung biopsy for undiagnosed pulmonary infiltrates in patients with hematological malignancies. Am J Hematol 2001; 68: 87-90.
119. Kalaycioglu M, Kavuru M, Tuason L, Bolwell B. Empiric prednisone therapy for pulmonary toxic reaction after high-dose chemotherapy containing carmustine. Chest 1995; 107: 482-7.
120. Alessandrino EP, Bernasconi P, Colombo A, et al. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Bone Marrow Transplant 2000; 25: 309-13.
121. Richter JE, Hastedt R, Dalton JF, et al. Pulmonary toxicity of bischloronitrosourea. Report of a case with transient response to corticosteroid therapy. Cancer 1979; 43: 1607-12.
122. Carruthers SA, Wallington M. Total body irradiation and pneumonitis risk: a review of outcomes. Br J Cancer 2004; 90: 2080-4.
123. Tryka AF, Godleski JJ, Fanta CH. Leukemic cell lysis pneumopathy. A complication of treated myeloblastic leukemia. Cancer 1982; 50: 2763-70.
124. Lester WA, Hull DR, Fegan CD, Morris TCM. Respiratory failure during induction chemotherapy for acute myelomonocytic leukaemia (FABM4Eo) with Ara-C and all-trans retinoic acid. Br J Haematol 2000; 109: 847-50.
125. Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000; 15:373-81.
126. Zisman DA, McCune WJ, Tino G, Lynch JPI. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 243-52.
127. Cannon GW. Methotrexate pulmonary toxicity. Rheum Dis Clin North Am 1997; 23: 917-37.
128. Clearkin R, Corris PA, Thomas SHL. Methotrexate pneumonitis in a patient with rheumatoid arthritis. Postgrad Med J 1997; 73: 603-4.
129. Fuhrman C, Parrot A, Wislez M, et al. Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis. Am J Respir Crit Care Med 2001; 164: 1186-91.
130. Kremer JM, Alarcon GS, Weinblatt ME, et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis. Arthritis Rheum 1997; 40: 1829-37.
131. Tomioka H, King TEJ. Gold-induced pulmonary disease: Clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 1997; 155: 1011-20.
132. Goldsack NR, Allen S, Lipman MCI. Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy. Sex Transm Infect 2003; 79: 337-8.
133. Tan L, Testa G, Yung T. Diffuse alveolar damage in BCGosis: A rare complication of intravesical bacillus Calmette-Guérin therapy for transitional cell carcinoma. Pathology 1999; 31: 55-6.
134. Allen JN. Drug-induced eosinophilic lung disease. Clin Chest Med 2004; 25: 77-88.
135. Sitbon O, Bidel N, Dussopt C, et al. Minocycline pneumonitis and eosinophilia: a report on 8 patients. Arch Intern Med 1994; 154: 1633-40.
136. Oberndorfer S, Beate U, Sabine U, et al. Churg Strauss syndrome during treatment of bronchial asthma with a leucotriene receptor antagonist presenting with polyneuropathy. Neurologia 2004; 19:134-8.
137. de Vriese ASP, Philippe J, Van Renterghem DM, et al. Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine (Baltimore) 1995; 74: 144-50.
138. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15:250-7.
139. Bourezane Y, Salard D, Hoen B, et al. DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome associated with nevirapine therapy. Clin Infect Dis 1998; 27: 1321-2.
140. Grasset L, Guy C, Ollagnier M. Cyclines and acne: pay attention to adverse drug reactions! A recent literature review. Rev Med Interne (Paris) 2003; 24:305-16.
141. Marrakchi C, Kanoun F, Kilani B, et al. Allopurinol induced DRESS syndrome. Rev Med Interne 2004; 25:252-4.
142. Kennedy JI, Myers JL, Plumb VJ, Fulmer JD. Amiodarone pulmonary toxicity. Clinical, radiologic and pathologic correlations. Arch Intern Med 1987;147: 50-5.
143. Ansoborlo P,Constans J,Le Métayer P,Conri C. Pneumopathy caused by amiodarone in internal medicine: eight cases. Rev Med Interne (Paris) 1993; 14: 698-704.
144. Malhorta A, Muse VV, Mark EJ. An 82-year-old man with dyspnea and pulmonary abnormalities. Case Records of the Massachusetts General Hospital - Case 12-2003. N Engl J Med 2003; 348: 1574-85.
145. Donaldson L, Grant IS, Naysmith MR, Thomas JS. Acute amiodarone-induced lung toxicity. Intensive Care Med 1998; 24: 626-30.
146. Handschin AE, Lardinois D, Schneiter D, et al. Acute amiodarone-induced pulmonary toxicity following lung resection. Respiration 2003; 70: 310-12.
147. Saussine M, Colson P, Alauzen M, Mary H. Postoperative acute respiratory distress syndrome. A complication of amiodarone associated with 100 percent oxygen ventilation. Chest 1992; 102:980-1.
148. Hawthorne HR, Wood MA, Stambler BS, et al. Can amiodarone pulmonary toxicity be predicted in patients undergoing implantable cardioverter defibrillator implantation? Pace 1993; 16: 2241-9.
149. van Mieghem W, Coolen L, Malysse I, et al. Amiodarone and the development of ARDS after lung surgery. Chest 1994; 105: 1642-5.
150. Charles PE, Doise JM, Quenot JP, et al. Amiodarone-related acute respiratory distress syndrome following sudden withdrawal of steroids. Respiration 2006; 73:248-9.
151. Alonso-Fernandez A, Alvarez-Sala R, Mediano O, et al. Late postoperative amiodarone pulmonary toxicity. An Med Interna 2003; 20: 419-20.
152. Kharabsheh S, Abendroth CS, Kozak M. Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. Am J Cardiol 2002; 89: 896-8.
153. Cohen AJ, King TE, Jr, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994; 149:1670-5.
154. Nizami IY, Kissner DG, Vissher DW, Dubaybo BA. Idiopathic bronchiolitis obliterans with organizing pneumonia. An acute and life-threatening syndrome. Chest 1995; 108: 271-7.
155. Baron FA, Hermanne J-P, Dowlati A, et al. Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21: 951-4.
156. Afessa B, Peters SG. Chronic lung disease after hematopoietic stem cell transplantation. Clin Chest Med 2005; 26: 571-586, vi.
157. Beasley MB, Franks TJ, Galvin JR, et al. Acute fibrinous and organizing pneumonia. A histologic pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002; 126:1064-70.
158. Coblyn JS, Weinblatt M. Acute interstitial pneumonitis and hypoxemia associated with rheumatoid arthritis. Med Times 1981; 109: 58-62.
159. Leng PH, Murillo B, Fraire A. Acute interstitial pneumonitis occurring after consolidation chemotherapy with high-dose cytarabine for acute myelogenous leukemia. Chest 1999; 116: 409-10.
160. Attar EC, Ervin T, Janicek M, et al. Acute interstitial pneumonitis related to gemcitabine. J Clin Oncol 2000; 18: 697-8.
161. Ostor AJ, Crisp AJ, Somerville MF, Scott DG. Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab. BMJ 2004; 329: 1266.
162. Pakhale S, Moltyaner Y, Chamberlain D, Lazar N. Rapidly progressive pulmonary fibrosis in a patient treated with danazol for idiopathic thrombocytopenic purpura. Can Respir J 2004; 11:55-7.
163. Pratt DS, Schwartz MI, May JJ, Dreisin RB. Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis. Thorax 1979; 34: 587-93.
164. Schwarz MI, Fontenot AP. Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med 2004; 25: 133-40.
165. Rostand RA, Feldman RL, Block ER. Massive hemothorax complicating heparin anticoagulation for pulmonary embolus. South Med J 1977; 70:1128-30.
166. Choi HK, Merkel PA, Cohen-Tervaert JW, et al. Alternating antineutrophil cytoplasmic antibody specificity. Drug-induced vasculitis in a patient with Wegener's granulomatosis. Arthritis Rheum 1999; 42:384-8.
167. Rabadi SJ, Khandekar JD, Miller HJ. Mitomycin-induced hemolytic uremic syndrome: case presentation and review of the literature. Cancer Treat Rep 1982; 66: 1244-7.
168. van der Lelie H, Baars JW, Rodenhuis S, et al. Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support. Cancer 1995; 76: 2338-42.
169. Teixeira L, Debourdeau P, Zammit C, et al. Gemcitabine-induced thrombotic microangiopathy. Presse Med 2002; 31: 740-2.
170. Walter RB, Joerger M, Pestalozzi BC. Gemcitabine-associated hemolytic-uremic syndrome. Am J Kidney Dis 2002; 40: 1-6.
171. Desramé J, Duvic C, Bredin C, et al. Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature. Rev Med Interne (Paris) 2005; 26: 179-88.
172. Carlson K, Smedmyr B, Hagberg H, et al. Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas. Bone Marrow Transplant 1993; 11: 205-8.
173. White DA, Schwartzberg LS, Kris MG, Bosl GJ. Acute chest pain syndrome during bleomycin infusions. Cancer 1987; 59: 1582-5.
174. Zijlstra EE, Wilson JHP, Ouwendijk RJT. Pleural fibrosis associated with ergotamine therapy. Eur J Intern Med 1990; 1: 245-7.
175. Bateman DE. Carbamazepine induced systemic lupus erythematosus: case report. Br Med J 1985; 291: 632-3.
176. Rubin RL. Drug-induced lupus. Toxicology 2005; 209: 135-47.
177. Yano S, Shimada K. Vasospastic angina after chemotherapy by with carboplatin and etoposide in a patient with lung cancer. Jpn Circulation J 1996; 60: 185-8.
178. Tsibiribi P, Descotes J, Lombard-Bohas C, et al. Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease. Bull Cancer 2006; 93: E27-30.
179. Cristofini P, Desnos M, Guenot O, et al. Cardiotoxicity of 5-fluorouracil: coronary spasm? Apropos of 2 cases with normal coronarography. Ann Med Interne (Paris) 1989; 140: 9-13.
180. Dodick DW. Triptans and chest symptoms: the role of pulmonary vasoconstriction. Cephalalgia 2004; 24: 298-304.
181. Uyarel H, Erden I, Cam N. Acute migraine attack, angina-like chest pain with documented ST-segment elevation and slow coronary flow. Acta Cardiologica 2005; 60: 221-3.
182. Rich JA, Singer DE. Cocaine-related symptoms in patients presenting to an urban emergency department. Ann Emerg Med 1991; 20: 616-21.
183. Olshaker JS. Cocaine chest pain. Emerg Med Clin North Am 1994; 12:391-6.
184. Pelz DM, Lownie SP, Fox AJ, Hutton LC. Symptomatic pulmonary complications from liquid acrylate embolization of brain arteriovenous malformations. Am J Neuroradiol 1995; 16: 19-26.
185. Zeller FA, Cannan CR, Prakash UB. Thoracic manifestations after esophageal variceal sclerotherapy. Mayo Clin Proc 1991; 66: 727-32.
186. Lauque D, Mazieres J, Rouzaud P, et al. Pulmonary embolism in patients taking estrogen-progestagen oral contraceptives. Presse Med 1998; 27: 1566-9.
187. Opatrny L, Warner MN. Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia. Am J Hematol 2004; 76: 240-4.
188. Shay DK, Fann LM, Jarvis WR. Respiratory distress and sudden death associated with receipt of a peripheral parenteral nutrition admixture. Infect Control Hosp Epidemiol 1997; 18: 814-17.
189. Reedy JS, Kuhlman JE, Voytovich M. Microvascular pulmonary emboli secondary to precipitated crystals in a patient receiving total parenteral nutrition. A case report and description of the high-resolution CT findings. Chest 1999; 115: 892-5.
190. Wesson DE, Rich RH, Zlotkin SH, Pencharz PB. Fat overload syndrome causing respiratory insufficiency. J Pediatr Surg 1984; 19: 777-8.
191. Czauderna P, Zbrzezniak G, Narozanski W, et al. Pulmonary embolism: a fatal complication of arterial chemoembolization for advanced hepatocellular carcinoma. J Pediatr Surg 2005; 40: 1647-50.
192. Fourme T, Vieillard-Baron A, Loubières Y, et al. Early fat embolism after liposuction. Anesthesiology 1998; 89: 782-4.
193. Rothmann C, Ruschel N, Streiff R, et al. Fat pulmonary embolism after liposuction. Ann Fr Anesth Reanim 2006; 25: 189-92.
194. Koessler MJ, Aebli N, Pitto RP. Fat and bone marrow embolism during percutaneous vertebroplasty. Anesth Analg 2003; 97: 293.
195. Yoo KY, Jeong SW, Yoon W, Lee J. Acute respiratory distress syndrome associated with pulmonary cement embolism following percutaneous vertebroplasty with polymethylmethacrylate. Spine 2004; 29: E294-7.
196. Righini M, Sekoranja L, Le GG, et al. Pulmonary cement embolism after vertebroplasty. Thromb Haemost 2006; 95: 388-9.
197. Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 169S-173S.
198. Aggarwal P, Wali JP. Enalapril-induced cough in the emergency department. J Emerg Med 1992; 10: 689-91.
199. Yemen TA. Small doses of sufentanil will produce violent coughing in young children. Anesthesiology 1998; 89:271-2.
200. Mitra S, Sinha PK, Anand LK, Gombar KK. Propofol-induced violent coughing. Anaesthesia 2000; 55: 707-8.
201. Morelock SY, Sahn SA. Drugs and the pleura. Chest 1999; 116:212-21.
202. Huggins JT, Sahn SA. Drug-induced pleural disease. Clin Chest Med 2004; 25: 141-54.
203. Camus P. Drug-induced pleural disease. In: Bouros D, ed. Pleural Disorders. New York: Marcel Dekker, 2004: 317-52.